Aktuelle Publikationen von Mitarbeitern oder unter Beteiligung von Mitarbeitern der Klinik und Poliklinik für Psychiatrie und Psychotherapie im Jahr 2003

Articles, Editorial Material, Letters, News Items, Notes und Reviews Bagli M, Papassotiropoulos A, Hampel H, Becker K, Jessen F, Bürger K, Ptok U, Rao ML, Möller HJ, Maier W, Heun R. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study. Eur Arch Psychiatry Clin Neurosci. 2003;253(1): 44-8 (Impact(2006)=3.042) Barkow K, Maier W, Ustün TB, Gänsicke M, Wittchen HU, Heun R. Risk factors for depression at 12month follow-up in adult primary health care patients with major depression: an international prospective study. J Affect Disord. 2003;76(1-3): 157-69 (Impact(2006)=3.138) Bayer TA, Schäfer S, Simons A, Kemmling A, Kamer T, Tepest R, Eckert A, Schüssel K, Eikenberg O, Sturchler-Pierrat C, Abramowski D, Staufenbiel M, Multhaup G. Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice. Proc Natl Acad Sci U S A. 2003;100(24): 14187-92 (Impact(2006)=9.643) Bellivier F, Golmard JL, Rietschel M, Schulze TG, Malafosse A, Preisig M, McKeon P, MynettJohnson L, Henry C, Leboyer M. Age at onset in bipolar I affective disorder: further evidence for three subgroups. Am J Psychiatry. 2003;160(5): 999-1001 (Impact(2006)=8.25) Belmaker B, Fitzgerald P, George MS, Lisanby SH, Pascual-Leone A, Schläpfer TE, Wassermann E. Managing the risks of repetitive transcranial stimulation. CNS Spectr. 2003;8(7): 489 (Impact(2006)=2.051) Bender S, Olbrich HM, Fischer W, Hornstein C, Schoene W, Falkai P, Haarmann C, Berger M, Gastpar M. Antipsychotic efficacy of the antidepressant trimipramine: a randomized, double-blind comparison with the phenothiazine perazine. Pharmacopsychiatry. 2003;36(2): 61-9 (Impact(2006)=2.849) Bonsignore M, Heun R. Mortality in Alzheimer's disease. Dement Geriatr Cogn Disord. 2003;15(4): 231-6 (Impact(2006)=2.511) Bosbach S, Kornblum C, Schröder R, Wagner M. Executive and visuospatial deficits in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome. Brain. 2003;126(Pt 5): 1231-40 (Impact(2006)=7.617) Bowden C, Maier W. Bipolar disorder and personality disorder. Eur Psychiatry. 2003;18: 9S-12S (Impact(2006)=1.463) Brune S, Kölsch H, Ptok U, Majores M, Schulz A, Schlösser R, Rao ML, Maier W, Heun R. Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease. J Neural Transm. 2003;110(9): 1041-50 (Impact(2006)=2.938) Clarke S, Zimmer A, Zimmer AM, Hill RG, Kitchen I. Region selective up-regulation of micro-, deltaand kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice. Neuroscience. 2003;122(2): 479-89 (Impact(2006)=3.427)

Danos P, Baumann B, Krämer A, Bernstein HG, Stauch R, Krell D, Falkai P, Bogerts B. Volumes of association thalamic nuclei in schizophrenia: a postmortem study. Schizophr Res. 2003;60(2-3): 141-55 (Impact(2006)=4.264) Domschke K, Kuhlenbäumer G, Schirmacher A, Lorenzi C, Armengol L, DiBella D, Gratacos M, Garritsen HS, Nöthen MM, Franke P, Sand P, Fritze J, Perez G, Maier W, Sibrowski W, Estivill X, Bellodi L, Ringelstein EB, Arolt V, Martin-Santos R, Catalano M, Stögbauer F, Deckert J. Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am J Med Genet B Neuropsychiatr Genet. 2003;117(1): 70-8 (Impact(2006)=4.463) Ehl C, Kölsch H, Ptok U, Jessen F, Schmitz S, Frahnert C, Schlösser R, Rao ML, Maier W, Heun R. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease. Int J Mol Med. 2003;11(2): 235-8 (Impact(2006)=1.854) Falkai P, Schneider-Axmann T, Honer WG, Vogeley K, Schönell H, Pfeiffer U, Scherk H, Block W, Träber F, Schild HH, Maier W, Tepest R. Influence of genetic loading, obstetric complications and premorbid adjustment on brain morphology in schizophrenia: a MRI study. Eur Arch Psychiatry Clin Neurosci. 2003;253(2): 92-9 (Impact(2006)=3.042) Frahnert C, Rao ML, Grasmäder K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;794(1): 35-47 (Impact(2006)=2.647) Franke P, Neef D, Weiffenbach O, Gänsicke M, Hautzinger M, Maier W. Psychiatrische Komorbidität in Risikogruppen für Opiatabhängigkeit: eine Untersuchung an opiatabhängigen und nichtopiatabhängigen BtmG-Inhaftierten. Fortschr Neurol Psychiatr. 2003;71(1): 37-44 (Impact(2006)=0.546) Franke P, Wendel B, Knapp M, Schwab SG, Neef D, Maier W, Wildenauer DB, Hoehe MR. Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence. Eur Psychiatry. 2003;18(1): 18-22 (Impact(2006)=1.463) Grasmäder K, Jaehde U, Lohmann PL, Rao ML. Optimierung des TDM von Lithiumsalzen durch computergestützte Dosisindividualisierung. Psychopharmakotherapie. 2003;10(1): 15-8 (Impact(2006)=0.19) Gustincich S, Batalov S, Beisel KW, Bono H, Carninci P, Fletcher CF, Grimmond S, Hirokawa N, Jarvis ED, Jegla T, Kawasawa Y, LeMieux J, Miki H, Raviola E, Teasdale RD, Tominaga N, Yagi K, Zimmer A, Hayashizaki Y, Okazaki Y. Analysis of the mouse transcriptome for genes involved in the function of the nervous system. Genome Res. 2003;13(6B): 1395-401 (Impact(2006)=10.256) Hein S, Bonsignore M, Barkow K, Jessen F, Ptok U, Heun R. Lifetime depressive and somatic symptoms as preclinical markers of late-onset depression. Eur Arch Psychiatry Clin Neurosci. 2003;253(1): 16-21 (Impact(2006)=3.042) Henkel V, Mergl R, Kohnen R, Maier W, Möller HJ, Hegerl U. Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ. 2003;326(7382): 200-1 (Impact(2006)=9.245) Herbon N, Werner M, Braig C, Gohlke H, Dütsch G, Illig T, Altmüller J, Hampe J, Lantermann A, Schreiber S, Bonifacio E, Ziegler A, Schwab S, Wildenauer D, van den Boom D, Braun A, Knapp M, Reitmeir P, Wjst M. High-resolution SNP scan of chromosome 6p21 in pooled samples from patients with complex diseases. Genomics. 2003;81(5): 510-8 (Impact(2006)=3.558)

Heun R, Kockler M, Ptok U. Lifetime symptoms of depression in Alzheimer's disease. Eur Psychiatry. 2003;18(2): 63-9 (Impact(2006)=1.463) Heun R, Kockler M, Ptok U. Subjective memory complaints of family members of patients with Alzheimer's disease and depression. Dement Geriatr Cogn Disord. 2003;16(2): 78-83 (Impact(2006)=2.511) Illes F, Rietz C, Fuchs M, Ohlraun S, Prell K, Rudinger G, Maier W, Rietschel M. Einstellung zu psychiatrisch-genetischer Forschung und prädiktiver Diagnostik. Hoffnungen und Befürchungen von Patienten, Angehörigen und der Allgemeinbevölkerung in Deutschland. Ethik in der Medizin. 2003;15: 268-81 Jessen F, Scheef L, Germeshausen L, Tawo Y, Kockler M, Kühn KU, Maier W, Schild HH, Heun R. Reduced hippocampal activation during encoding and recognition of words in schizophrenia patients. Am J Psychiatry. 2003;160(7): 1305-12 (Impact(2006)=8.25) Johansson C, Willeit M, Smedh C, Ekholm J, Paunio T, Kieseppä T, Lichtermann D, Praschak-Rieder N, Neumeister A, Nilsson LG, Kasper S, Peltonen L, Adolfsson R, Schalling M, Partonen T. Circadian clock-related polymorphisms in seasonal affective disorder and their relevance to diurnal preference. Neuropsychopharmacology. 2003;28(4): 734-9 (Impact(2006)=5.889) Keltikangas-Järvinen L, Elovainio M, Kivimäki M, Lichtermann D, Ekelund J, Peltonen L. Association between the type 4 dopamine receptor gene polymorphism and novelty seeking. Psychosom Med. 2003;65(3): 471-6 (Impact(2006)=3.857) Kirschling CM, Kölsch H, Frahnert C, Rao ML, Maier W, Heun R. Polymorphism in the BACE gene influences the risk for Alzheimer's disease. Neuroreport. 2003;14(9): 1243-6 (Impact(2006)=2.137) Klosterkötter J, Maier W. Früherkennung und Frühintervention bei psychischen Störungen. Ansätze zur Prävention und zur Vermeidung von Chronifizierungen. Dtsch Ärztbl. 2003;100: B1862-B1863 Kölsch H, Ptok U, Mohamed I, Schmitz S, Rao ML, Maier W, Heun R. Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2003;121(1): 128-30 (Impact(2006)=4.463) Kosel M, Frick C, Lisanby SH, Fisch HU, Schläpfer TE. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology. 2003;28(11): 2045-8 (Impact(2006)=5.889) Kosel M, Schläpfer TE. Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry. CNS Spectr. 2003;8(7): 515-21 (Impact(2006)=2.051) Kovalenko S, Bergmann A, Schneider-Axmann T, Ovary I, Majtenyi K, Havas L, Honer WG, Bogerts B, Falkai P. Regio entorhinalis in schizophrenia: more evidence for migrational disturbances and suggestions for a new biological hypothesis. Pharmacopsychiatry. 2003;36 Suppl 3: S158-61 (Impact(2006)=2.849) Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Müller DJ, Schulze TG, Reshef A, Blanaru M, Gathas S, Goichman R, Rietschel M, Dobrusin M, Bachner-Melman R, Nemanov L, Belmaker RH, Maier W, Ebstein RP. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. Am J Med Genet B Neuropsychiatr Genet. 2003;119(1): 35-9 (Impact(2006)=4.463) Krystal JH, Petrakis IL, Krupitsky E, Schütz C, Trevisan L, D'Souza DC. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci. 2003;1003: 176-84 (Impact(2006)=1.93)

Kühn KU, Quednow BB, Thiel M, Falkai P, Maier W, Elger CE. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav. 2003;4(6): 674-9 (Impact(2006)=2.026) Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lönnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoëga T, Helgason T. Genome scan metaanalysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003;73(1): 34-48 (Impact(2006)=12.629) Lohmann PL, Bagli M, Krauss H, Müller DJ, Schulze TG, Fangerau H, Ludwig M, Barkow K, Held T, Heun R, Maier W, Rietschel M, Rao ML. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients. Pharmacopsychiatry. 2003;36(2): 73-8 (Impact(2006)=2.849) Lohmann PL, Frahnert C, Grasmäder K, Hiemke C, Laux G, Rao ML. Klinische Relevanz des CYP2D6-Polymorphismus für die Therapie mit Antidepressiva und Neuroleptika - Kasuistiken von CYP2D6-Poor-Metabolisern. Psychopharmakotherapie. 2003;10(1): 35-8 (Impact(2006)=0.19) Maier W. Prospects for genetic research in psychiatry. Curr Opin Psychiatry. 2003;16(Suppl 2): S53-61 (Impact(2006)=1.081) Maier W, Cornblatt BA, Merikangas KR. Transition to schizophrenia and related disorders: toward a taxonomy of risk. Schizophr Bull. 2003;29(4): 693-701 (Impact(2006)=4.352) Maier W, Zobel A, Rietschel M. Genetics of schizophrenia and affective disorders. Pharmacopsychiatry. 2003;36 Suppl 3: S195-202 (Impact(2006)=2.849) Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, Hermann E, Kuss HJ, Laux G, Oehl W, Rao ML, Rollmann N, Weigmann H, Weber-Labonte M, Hiemke C. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Pharmacopsychiatry. 2003;36(3): 98-104 (Impact(2006)=2.849) Newen A, Vogeley K. How not to find the neural signature of self-consciousness - Reply to Dorothee Legrand. Conscious Cogn. 2003;12(4): 547-48 (Impact(2006)=1.825) Newen A, Vogeley K. Self-representation: searching for a neural signature of self-consciousness. Conscious Cogn. 2003;12(4): 529-43 (Impact(2006)=1.825) Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci. 2003;23(6): 2453-8 (Impact(2006)=7.453) Rao ML, Kölsch H. Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia. Psychoneuroendocrinology. 2003;28 Suppl 2: 83-96 (Impact(2006)=4.85) Riedel M, Krönig H, Schwarz MJ, Engel RR, Sikorski C, Kühn KU, Behrens S, Möller HJ, Ackenheil M, Müller N. Investigation of the ICAM-1 G241A and A469G gene polymorphisms in schizophrenia. Mol Psychiatry. 2003;8(3): 257-8 (Impact(2006)=11.804)

Rohrmeier T, Putzhammer A, Sartor H, Knapp M, Albus M, Borrmann-Hassenbach M, Lichtermann D, Wildenauer D, Schwab S, Maier W, Klein HE, Eichhammer P. Keine Assoziation des - 141C-Ins/DelPolymorphismus im Gen des Dopaminrezeptor D2 mit Schizophrenie. Psychiatr Prax. 2003;30 Suppl 2: S212-5 (Impact(2006)=2.149) Rutten BP, Wirths O, Van de Berg WD, Lichtenthaler SF, Vehoff J, Steinbusch HW, Korr H, Beyreuther K, Multhaup G, Bayer TA, Schmitz C. No alterations of hippocampal neuronal number and synaptic bouton number in a transgenic mouse model expressing the beta-cleaved C-terminal APP fragment. Neurobiol Dis. 2003;12(2): 110-20 (Impact(2006)=4.128) Scherk H, Vogeley K, Falkai P. Die Bedeutung von Interneuronen bei affektiven und schizophrenen Erkrankungen. Fortschr Neurol Psychiatr. 2003;71 Suppl 1: S27-32 (Impact(2006)=0.546) Schläpfer TE. Progress in therapeutic brain stimulation in neuropsychiatry. CNS Spectr. 2003;8(7): 488 (Impact(2006)=2.051) Schmidt S, Marrosu GM, Kölsch H, Haase CG, Ferenczik S, Sokolowski P, Köhler W, Schmidt M, Papassotiropoulos A, Heun R, Grosse-Wilde H, Klockgether T. Genetic variations and humoral immune responses to myelin oligodendroglia glycoprotein in adult phenotypes of X-linked adrenoleukodystrophy. J Neuroimmunol. 2003;135(1-2): 148-53 (Impact(2006)=2.88) Schmidt S, Papassotiropoulos A, Sotgiu S, Kölsch H, Arru G, Fois ML, Haase CG, Schmitz S, König N, Harzheim M, Heun R, Klockgether T. Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis. J Neurol. 2003;250(5): 607-11 (Impact(2006)=2.984) Schoepf D, Heun R, Weiffenbach O, Herrmann S, Maier W. 4-Wochen-Prävalenz somatoformer Störungen und assoziierte psychosoziale Beeinträchtigung. Nervenarzt. 2003;74(3): 245-51 (Impact(2006)=0.711) Schütz B, Damadzic R, Weihe E, Eiden LE. Identification of a region from the human cholinergic gene locus that targets expression of the vesicular acetylcholine transporter to a subset of neurons in the medial habenular nucleus in transgenic mice. J Neurochem. 2003;87(5): 1174-83 (Impact(2006)=4.26) Schulze TG, Cichon S, Nöthen MM, Propping P, Maier W, Rietschel M. Is there a phenotypic difference between probands in case-control versus family-based association studies? Am J Med Genet B Neuropsychiatr Genet. 2003;118(1): 25-6; author reply 27-8 (Impact(2006)=4.463) Schumacher J, Otte AC, Becker T, Sun Y, Wienker TF, Wirth B, Franke P, Abou Jamra R, Propping P, Deckert J, Nöthen MM, Cichon S. No evidence for DUP25 in patients with panic disorder using a quantitative real-time PCR approach. Hum Genet. 2003;114(1): 115-7 (Impact(2006)=3.662) Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet. 2003;72(1): 185-90 (Impact(2006)=12.629) Schwab SG, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M, Trixler M, Gross M, Schulze TG, Rietschel M, Lerer B, Maier W, Wildenauer DB. Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia. Schizophr Res. 2003;65(1): 19-25 (Impact(2006)=4.264)

Segurado R, Detera-Wadleigh SD, Levinson DF, Lewis CM, Gill M, Nurnberger JI, Craddock N, DePaulo JR, Baron M, Gershon ES, Ekholm J, Cichon S, Turecki G, Claes S, Kelsoe JR, Schofield PR, Badenhop RF, Morissette J, Coon H, Blackwood D, McInnes LA, Foroud T, Edenberg HJ, Reich T, Rice JP, Goate A, McInnis MG, McMahon FJ, Badner JA, Goldin LR, Bennett P, Willour VL, Zandi PP, Liu J, Gilliam C, Juo SH, Berrettini WH, Yoshikawa T, Peltonen L, Lönnqvist J, Nöthen MM, Schumacher J, Windemuth C, Rietschel M, Propping P, Maier W, Alda M, Grof P, Rouleau GA, DelFavero J, Van Broeckhoven C, Mendlewicz J, Adolfsson R, Spence MA, Luebbert H, Adams LJ, Donald JA, Mitchell PB, Barden N, Shink E, Byerley W, Muir W, Visscher PM, Macgregor S, Gurling H, Kalsi G, McQuillin A, Escamilla MA, Reus VI, Leon P, Freimer NB, Ewald H, Kruse TA, Mors O, Radhakrishna U, Blouin JL, Antonarakis SE, Akarsu N. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet. 2003;73(1): 49-62 (Impact(2006)=12.629) Smith GN, Lang DJ, Kopala LC, Lapointe JS, Falkai P, Honer WG. Developmental abnormalities of the hippocampus in first-episode schizophrenia. Biol Psychiatry. 2003;53(7): 555-61 (Impact(2006)=7.154) Tepest R, Wang L, Miller MI, Falkai P, Csernansky JG. Hippocampal deformities in the unaffected siblings of schizophrenia subjects. Biol Psychiatry. 2003;54(11): 1234-40 (Impact(2006)=7.154) Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, Becker T, Freudenberg J, Jönsson EG, Mattila-Evenden M, Sedvall GC, Czerski PM, Kapelski P, Hauser J, Maier W, Rietschel M, Propping P, Nöthen MM, Cichon S. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet. 2003;73(6): 1438-43 (Impact(2006)=12.629) Vogeley K, Tepest R, Schneider-Axmann T, Hütte H, Zilles K, Honer WG, Falkai P. Automated image analysis of disturbed cytoarchitecture in Brodmann area 10 in schizophrenia. Schizophr Res. 2003;62(1-2): 133-40 (Impact(2006)=4.264) Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci U S A. 2003;100(3): 1393-8 (Impact(2006)=9.643) Wölwer W, Buchkremer G, Häfner H, Klosterkötter J, Maier W, Möller H-J, Gaebel W. German Research Network on Schizophrenia - bridging the gap between research and care. Eur Arch Psychiatry Clin Neurosci. 2003;253: 321-9 (Impact(2006)=3.042) Zill P, Ackenheil M, Rietschel M, Maier W. Molekulare Genetik affektiver Störungen: Befunde und Strategien zur Identifikation der genetischen Ursachen. Psychoneuro. 2003;29(1): 51-6

Bücher und Buchbeiträge Maier W (2003) Genetics of anxiety. In: Kasper S, Den Boer JA, Sitsen JMA (Eds.) Handbook of depression and anxiety. 2nd ed. Dekker, New York (189-205). Maier W (2003) Psychiatric genetics: overview on achievements, problems, perpectives. In: Leboyer M, Bellivier F (Eds.) Psychiatric genetics. Methods and reviews. Methods in molecular medicine, 77. Humana Press, Totowa (3-20). Maier W, Franke P (2003) Biologie und Genetik der Sucht. In: Madea B, Brinkmann B (Hrsg.) Handbuch gerichtliche Medizin, 2. Springer, Berlin (639-661). Maier W, Merikangas KR (2003) Genetics of depression. In: Kasper S, Den Boer JA, Sitsen JMA (Eds.) Handbook of depression and anxiety. 2nd ed. Dekker, New York (165-187).

Maier W, Schwab S, Rietschel M (2003) Genetik psychiatrischer Störungen. In: Möller H-J, Laux G, Kapfhammer H-P (Hrsg.) Psychiatrie und Psychotherapie. 2. Aufl. Springer, Berlin (69-105).